Exposure to MF59-adjuvanted influenza vaccines during pregnancy-A retrospective analysis

Vaccine

Volumn 28, Issue 7, 2010, Pages 1877-1880

  Tsai, Theodore ^a   Kyaw, Moe H ^a   Novicki, Deborah ^a   Nacci, Pantaleo ^b   Rai, Saroj ^a   Clemens, Ralf ^b  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (United States)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Influenza vaccine; MF59 adjuvant; Pregnant women; Safety

Indexed keywords

INFLUENZA VACCINE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;

ARTICLE; CLINICAL TRIAL; DRUG SAFETY; ECTOPIC PREGNANCY; FETAL WELL BEING; FETUS DEVELOPMENT; FETUS RISK; FIRST TRIMESTER PREGNANCY; HUMAN; INDUCED ABORTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC; PERINATAL DEVELOPMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH; TERATOGENICITY;

ADJUVANTS, IMMUNOLOGIC; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INFLUENZA VACCINES; POLYSORBATES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; SQUALENE;

EID: 75249088809     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.11.077     Document Type: Article

References (22)

1. Mak T.K., Mantgtani P., Leese J., Watson J.M., and Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect Dis 8 (2008) 44-52
2. Skowronski D.M., and DeSerres G. Is routine influenza immunization warranted in early pregnancy?. Vaccine 27 (2009) 4754-4770
3. Lindsay L., Jackson L.A., Savitz D.A., Weber D.J., Koch G.G., Kong L., et al. Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women. Am J Epidemiol 163 (2006) 838-848
4. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., and Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 148 (1998) 1094-1102
5. Hartert T.V., Neuzil K.M., Shintani A.K., Mitchell E.F., Snowden M.S., Wood L.B., et al. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol 189 (2003) 1705-1712
6. WHO. New influenza A (H1N1) virus: global epidemiological situation, June 2009. Weekly epidemiological record 2009; 25:249-57.
7. Jamieson D.J., Honein M.A., Rasmussen S.A., Williams J.L., Swedlow D.L., Biggerstaff M.S., et al. H1N12009 influenza virus infection during pregnancy in the USA. Lancet 374 9688 (2009) 451-458
8. European Centre for Disease Prevention and Control. Influenza A (H1N1) Risk Assessment. ECDC internal decision, 18 May 2009/Revised 12 June 2009. Available from URL: http://www.ecdc.europa.eu/en/healthtopics/Documents/0906_Influenza_AH1N1_Risk_Assessment.pdf [Accessed October 8, 2009].
9. National Center for immunization respiratory diseases. Use of influenza A (H1N1) 2009 monovalent vaccine. Recommendation of the advisory committee on immunization practices (ACIP) 2009. MMWR 58 (2009) 1-6
10. Strategic advisory group of experts on immunization. Report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009. Weekly Epidemiology Record 2009; 84:301-308.
11. Clark T.W., Pareek M., Hoshcler K., Dillon H., Nicholson K.G., Groth N., et al. Trial of influenza A (H1N1) 2009 monovalent MF59-adjuvanted vaccine-preliminary report. New Eng J Med (2009) 10.1056/NEJMoa0907650
12. Keitel W., Groth N., Lattanzi M., et al. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial. Vaccine 28 (2010) 840-848
13. O'Hagan D, Tsai TF. MF59. A safe and potent oil in water emulsion adjuvant for influenza vaccines, which induces enhanced protection against virus challenge. In: Rappouli R, Del Giudice, G (eds.). Influenza Vaccines for the Future, second ed. Basel, Switzerland: Birkhäuser Verlag AG, in press.
14. Schultze V., D'Agosto D., Wack A., Novicki D., Zorn J., and Hennig R. Safety of MF59 adjuvants. Vaccine 26 (2008) 3209-3222
15. Munoz F.M., Greisinger A.J., Wehmanen O.A., Mouzoon M.E., Hoyle J.C., Smith F.A., et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 192 (2005) 1098-1106
16. Black S.B., Shinefield H.R., France E.K., Fireman B.H., Platt S.T., and Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol 21 (2004) 333-339
17. France E.K., Smith-Ray R., McClure D., Hambidge S., Xu S., Yamasaki K., et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. Arch Pediatr Adolesc Med 160 (2006) 1277-1283
18. Zaman K., Roy E., Arifeen S.E., Rahman M., Ragib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. New Eng J Med 359 (2008) 1444-1464
19. Fiore A.E., Shay D.K., Broder K., Iskander J.K., Uyeki T.M., Mootrey G., et al. Prevention and control of seasonal influenza with vaccines. Recommendation of the Advisory Committee for Immunization Practices (ACIP), 2009. MMWR 58 RR-8 (2009) 1-56
20. Descamps D., Hardt K., Spiessens B., Izurieta P., Verstraeten T., Breuer T., et al. Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Hum Vacc 5 (2009) 332-340
21. Centers for Disease Control and Prevention. Estimated Pregnancy Rates by Outcomes for the United States, 1990-2004. National Vital Statistics Reports, vol. 56, Number 15, April 14, 2008.
22. Yang Y., Sugimoto J.D., Halloran M.E., Basta N.E., Chao D.L., Matrajt L., et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science (2009) 10.1126/science.1177373